Chemoinformaics analysis of 3,5-bis(1,1-dimethylethyl)-4-hydroxy-
| Molecular Weight | 722.064 | nRot | 10 |
| Heavy Atom Molecular Weight | 650.496 | nRig | 20 |
| Exact Molecular Weight | 721.528 | nRing | 3 |
| Solubility: LogS | -5.444 | nHRing | 1 |
| Solubility: LogP | 8.839 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 123 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 52 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 71 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 45 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 128.404 |
| nHD | 2 | BPOL | 78.1457 |
| QED | 0.236 |
| Synth | 3.477 |
| Natural Product Likeliness | 0.197 |
| NR-PPAR-gamma | 0.827 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.902 |
| Pgp-sub | 0.007 |
| HIA | 0.983 |
| CACO-2 | -6.605 |
| MDCK | 0.00000563 |
| BBB | 0.587 |
| PPB | 0.970004 |
| VDSS | 3.875 |
| FU | 0.0268608 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.105 |
| CYP2c19-inh | 0.215 |
| CYP2c19-sub | 0.948 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.559 |
| CYP2d6-inh | 0.642 |
| CYP2d6-sub | 0.478 |
| CYP3a4-inh | 0.58 |
| CYP3a4-sub | 0.939 |
| CL | 5.411 |
| T12 | 0.161 |
| hERG | 0.413 |
| Ames | 0.007 |
| ROA | 0.02 |
| SkinSen | 0.882 |
| Carcinogencity | 0.011 |
| EI | 0.072 |
| Respiratory | 0.908 |
| NR-Aromatase | 0.953 |
| Antiviral | Yes |
| Prediction | 0.853195 |